Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Mavroudis D, Alexopoulos A, Ziras N, Malamos N, Kouroussis C, Kakolyris S, Agelaki S, Kalbakis K, Tsavaris N, Potamianou A, Rigatos G, Georgoulias V.
Mavroudis D, et al. Among authors: rigatos g.
Ann Oncol. 2000 Oct;11(10):1249-54. doi: 10.1023/a:1008351310818.
Ann Oncol. 2000.
PMID: 11106112
Free article.
Clinical Trial.